BRC News

The non-commercial trial supported by our NIHR BRC aims to treat at least 12 patients over the next two years.

Patients on the BRC-supported trial were treated with a short course immunotherapy before surgery instead of post-op chemotherapy.

Survival rates improved significantly over time thanks to advances in treatments and care, although the team also identified inequalities, with higher mortality in deprived areas.

The trial, led by Professor Siow Ming Lee, aims to enrol more than 600 participants worldwide.

CMT is a group of inherited neuromuscular conditions that affect walking and muscle tone and can cause foot deformities.

The study was led by researchers from UCLH, UCL and the University of Nottingham.

UCLH have recruited the first participant in the world to a new global phase I study for early Alzheimer’s Disease.

Mesothelioma is a rare and aggressive cancer of the lining of the lung.

The aim is to bring new treatments to patients sooner and make the NHS a more attractive place to do research.

Leading international experts, among them UCLH and UCL’s Professor John Bridgewater, are calling for urgent action to improve outcomes for people with bile duct cancer.

A research study taking place across GP practices is looking at whether a new cholesterol-lowering pill can help prevent heart attacks and strokes.

Researchers found that prehospital emergency intubation of high-risk trauma patients could save 170 lives each year in the UK.

239 people have so far joined the registry of healthy volunteers willing to be contacted about taking part in health research.

The trial aims to improve independence for people who are paralysed.

Premature birth can pose risks to a newborn baby, as many organs are still developing in the final weeks of pregnancy.